XTAI
1474
Market cap40mUSD
Oct 08, Last price
10.05TWD
1D
0.50%
1Q
-4.29%
Jan 2017
-10.67%
Name
Honmyue Enterprise Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Honmyue Enterprise Co., Ltd., based in Changhua, Taiwan, is a textile manufacturer and distributor operating under its nüwa and Honyi brands. The company offers a diverse range of fabrics, including nylon, various polyester types (such as spun and solution-dyed), vinyl mesh, textilene, TC/TR blends, and yarn-dyed materials. In addition to traditional textiles, Honmyue also produces a comprehensive line of medical-grade garments and linens. This includes items like surgical and isolation gowns, drapes, medical scrubs, hospital bedsheets, fitted sheets, and pillowcases. Their specialized offerings further extend to body bags, tent fabrics, and face masks, among other personal protective equipment. These materials serve a wide array of applications, spanning industrial uses, luggage and baggage manufacturing, indoor and outdoor home furnishings, sports apparel, and specialized medical textile requirements. Honmyue Enterprise Co., Ltd. has been in operation since its establishment in 1970.
Key people
Mingzhou Ye
Chairman of the Board · since 2018
General Manager, Director · since 2024
Jinchang Hong
Executive Deputy General Manager-Business Division · since 2022
Shaorui Chen
Chief Information Security Officer · since 2023
Lizhe Pan
Corporate Governance Officer · since 2025
Huina Xie
Head of Finance · since 2022
Suqing Zhuo
Corporate Governance Officer · since 2019
Zhenhui Cai
Director · since 2021
Jinfeng Chen
Vice Chairman of the Board · since 2011
Director · since 2015
Maolin Wang
Director · since 2021
Renxing Xu
Director · since 2021
Junlin Ye
Director · since 2021
Hongzhao Lin
Independent Director · since 2015
Zhenqi Xiao
Independent Director · since 2018
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||